Stockreport

Xenon Pharmaceuticals Inc (XENE) Looking At a $2 Billion Opportunity Here [Yahoo! Finance]

Xenon Pharmaceuticals Inc. - Common Shares  (XENE) 
Last xenon pharmaceuticals inc. - common shares earnings: 11/5 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.xenon-pharma.com
PDF data from the Phase 3 X-TOLE2 study of its epilepsy drug candidate, azetukalner, at the American Academy of Neurology Annual Meeting in Chicago. Xenon Pharmaceuticals [Read more]